Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Friendly Pharmaceutical is a China-based pharmaceutical manufacturer focused on biochemical active pharmaceutical ingredients and finished-dose products. The company appears to operate primarily as a commercial manufacturer rather than an innovative clinical-stage biotech, with activities spanning API production, tablets, granules, capsules, powders, and syrups, as well as pharmaceutical import/export. Publicly available product and regulatory references indicate marketed or registered products including pancreatin, pepsin, multi-enzyme tablets, gastric mucin, and porcine thyroid-related materials, with a particular emphasis on digestive-enzyme and animal-derived biochemical products. The company holds drug manufacturing and GMP-related qualifications in China and has patented manufacturing processes for pancreatin and related biochemical products. Overall, it looks best characterized as an active private specialty pharma/API company serving commercial and manufacturing markets rather than a pipeline-driven R&D biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Friendly Pharmaceutical.